MP16-15 THE DIAGNOSTIC ROLE OF MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING BEFORE INITIAL PROSTATE BIOPSY: THE DEVELOPMENT OF NOMOGRAMS PREDICTING THE OUTCOMES OF PROSTATE BIOPSY

Dong Fang,Chenglin Zhao,Da Ren,Wei Yu,Rui Wang,Huihui Wang,Xuesong Li,Xiaoying Wang,Zhongcheng Xin,Liqun Zhou

DOI: https://doi.org/10.1016/j.juro.2016.02.2580

2016-01-01

Abstract:You have accessJournal of UrologyProstate Cancer: Detection & Screening I1 Apr 2016MP16-15 THE DIAGNOSTIC ROLE OF MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING BEFORE INITIAL PROSTATE BIOPSY: THE DEVELOPMENT OF NOMOGRAMS PREDICTING THE OUTCOMES OF PROSTATE BIOPSY Dong Fang, Chenglin Zhao, Da Ren, Wei Yu, Rui Wang, Huihui Wang, Xuesong Li, Xiaoying Wang, Zhongcheng Xin, and Liqun Zhou Dong FangDong Fang More articles by this author , Chenglin ZhaoChenglin Zhao More articles by this author , Da RenDa Ren More articles by this author , Wei YuWei Yu More articles by this author , Rui WangRui Wang More articles by this author , Huihui WangHuihui Wang More articles by this author , Xuesong LiXuesong Li More articles by this author , Xiaoying WangXiaoying Wang More articles by this author , Zhongcheng XinZhongcheng Xin More articles by this author , and Liqun ZhouLiqun Zhou More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2016.02.2580AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES To investigate the effectiveness of multiparametric magnetic resonance imaging (mpMRI) in diagnosing prostate cancer (PCa) and high-grade prostate cancer (HGPCa) before transrectal ultrasound (TRUS)-guided biopsy. METHODS The clinical data of 894 patients who received TRUS-guided biopsy and prior mpMRI test from a large Chinese center was reviewed. All MRIs were re-reviewed and assigned as Grade 0-2 (negative; suspicious; positive) based on PI-RADS criteria. We constructed two predictive models both in predicting PCa and HGPCa (Gleason score≥7): Model 1 with MRI and Model 2 without MRI. Other clinical factors include age, digital rectal examination, PSA, free-PSA, volume and TRUS. RESULTS PCa and HGPCa were present in 460 (51.5%) and 357 (39.9%) patients each. An MRI Grade 0-2 was assigned in 324 (36.2%), 193 (21.6%) and 377 (42.2%) patients, respectively, which was related to the presence of PCa (p<0.001) and HGPCa (p<0.001). Particularly in patients with age=55, the assignment of MRI Grade 0 was correlated with extremely low rate of PCa (1/27) and no HGPCa. In univariate analysis, elder Age, elevated PSA, lower percentage of free-PSA, suspicious DRE, positive TRUS result, and smaller PV were also related to the presence of PCa and HGPCa. We constructed two predictive models based on multivariate logistic analysis. The c-index of Model 1 and Model 2 for predicting the presence of PCa was 0.875 and 0.841 each (p<0.001), while for predicting the presence of HGPCa was 0.889 and 0.852 (p<0.001). Model 1 exhibit higher sensitivity and specificity at same cut-offs and decision curve analysis also suggested the favorable clinical utility of Model 1. CONCLUSIONS Prostate MRI test before biopsy could well predict the presence of PCa and HGPCa, especially in younger patients. The incorporation of MRI in nomograms could increase predictive accuracy. © 2016FiguresReferencesRelatedDetails Volume 195Issue 4SApril 2016Page: e166 Advertisement Copyright & Permissions© 2016MetricsAuthor Information Dong Fang More articles by this author Chenglin Zhao More articles by this author Da Ren More articles by this author Wei Yu More articles by this author Rui Wang More articles by this author Huihui Wang More articles by this author Xuesong Li More articles by this author Xiaoying Wang More articles by this author Zhongcheng Xin More articles by this author Liqun Zhou More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...